Professor David Nutt: Alcohol, GABA & SENTIA Science
Professor David Nutt: the neuroscientist behind SENTIA’s research into alcohol, GABA and the science of social drinking.
Who is Professor David Nutt?
Professor David Nutt is a British neuropsychopharmacologist — a scientist who studies how drugs and brain chemistry affect thought, mood and behaviour.
He is the Edmond J. Safra Professor of Neuropsychopharmacology at Imperial College London, where he has worked across alcohol, addiction, psychedelics, brain imaging and psychopharmacology. Before Imperial, he held posts at Oxford and Bristol and spent two years as Chief of the Section of Clinical Science at the US National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
Today, he is also co-founder and Chief Scientific Officer of GABA Labs, the research company behind SENTIA. His connection to the brand is not simply that he knows a lot about drinks. It is that he has spent decades asking a much more interesting question:
What does alcohol do in the brain and which parts of that experience do people genuinely value?
Why is Professor Nutt important to SENTIA?
Alcohol has been one of humanity’s most familiar ways of changing brain state for thousands of years.
People drink because alcohol does things they value. At lower doses, it can help people feel more relaxed, less inhibited and more socially at ease. GABA Labs’ peer-reviewed research argues that an important part of these early effects comes from alcohol enhancing GABA — the brain’s principal inhibitory neurotransmitter and one of its key regulatory systems.
Professor Nutt’s expertise matters because he has spent much of his scientific career studying exactly this territory: alcohol, GABA receptors, addiction and the way psychoactive compounds alter brain function. His early research included work on the GABA-benzodiazepine receptor system, while his period at the US National Institute on Alcohol Abuse and Alcoholism placed alcohol pharmacology directly at the centre of his work.
That history eventually led to the question behind SENTIA: Could you learn from what alcohol does well socially, identify part of the underlying mechanism, and find another way to approach it? That is the starting point for functional alcohol alternatives.
Alcohol showed us where to look
At lower blood-alcohol concentrations, Professor Nutt and colleagues describe alcohol’s relaxing and sociability-promoting effects as being linked in part to enhanced GABA activity. As alcohol levels rise, however, its pharmacology becomes much broader and begins affecting many other brain systems.
That distinction is central to the SENTIA idea. Alcohol solved a real human problem: social ease. The scientific opportunity is to understand why that works, then investigate whether plant-derived compounds can interact with some of the same useful biology without simply recreating everything ethanol does.
From alcohol science to SENTIA
Professor Nutt had been publicly discussing the possibility of more selective alcohol alternatives long before SENTIA existed. In 2013, Imperial reported his work investigating compounds designed to reproduce some of alcohol’s desirable effects by targeting GABA receptors more selectively.
GABA Labs later developed that research programme further. Its 2022 peer-reviewed paper, Functional Alternatives to Alcohol, set out the scientific rationale: understand the desirable and undesirable effects of alcohol, identify the biological mechanisms involved, then investigate natural or synthetic compounds capable of approaching the former without reproducing the latter.
SENTIA emerged from that research direction. For Professor Nutt, the broader principle is consistent with much of his career: give people better information and better choices.
That applies to medicines. It applies to drug policy. And it applies to what adults choose to drink.
Professor David Nutt: key facts
- He is the Edmond J. Safra Professor of Neuropsychopharmacology at Imperial College London and directs its Neuropsychopharmacology Unit.
- He spent two years as Chief of the Section of Clinical Science at the US National Institute on Alcohol Abuse and Alcoholism, giving him direct academic experience in alcohol and addiction science.
- His early scientific work helped develop understanding of the GABA-benzodiazepine receptor system, including influential research on inverse agonism.
- In 2010, he co-authored the famous Lancet drug-harm analysis which ranked alcohol as the most harmful drug overall when harm to the individual and harm to wider society were combined. Alcohol scored 72, ahead of heroin at 55 and crack cocaine at 54.
- He was dismissed as Chair of the UK Advisory Council on the Misuse of Drugs in 2009 after publicly arguing that government drug classifications were not aligned with scientific evidence, particularly around cannabis and MDMA. The controversy became a major debate about the independence of scientific advice.
- He founded Drug Science in 2010, an independent charity created to provide evidence on drugs and drug policy free from political or commercial influence.
- He helped lead the modern revival of psychedelic research at Imperial, working on psilocybin, LSD, MDMA, DMT and other psychoactive compounds. Imperial’s psychedelic research programme has conducted landmark brain-imaging and clinical studies.
- He led pioneering MDMA brain-imaging research examining how the drug changes emotional brain circuitry.
- He also co-authored an early clinical study of MDMA-assisted psychotherapy for alcohol-use disorder, which Imperial described as the first study of its kind.
- He took the witness stand in South Africa’s “Trial of the Plant” cannabis case, appearing as an expert witness for Myrtle Clarke and Jules Stobbs in their constitutional challenge to cannabis prohibition.
- He won the 2013 John Maddox Prize for Standing up for Science, awarded for his commitment to communicating scientific evidence despite opposition and hostility.
- Imperial lists more than 500 original research papers to his name, alongside a similar number of reviews and book chapters, eight government reports and over 40 books.
- His books include Drink? The New Science of Alcohol and Your Health, Drugs Without the Hot Air, Cannabis: Seeing Through the Smoke and Psychedelics: The Revolutionary Drugs That Could Change Your Life.
- The Standard named him among its 100 people shaping London in 2024, recognising his influence in science and medicine.
- One of his most famous thought experiments compared the risks of taking ecstasy with those of horse riding — which he jokingly called “equasy” — to make a serious point about how inconsistently society thinks about risk.
What does Professor Nutt believe?
A thread runs through Professor Nutt’s work: people should be able to make decisions using evidence rather than assumption. That does not mean pretending psychoactive substances are harmless. Quite the opposite. His work has repeatedly tried to quantify both their risks and their benefits more accurately. It means understanding what something does, how it works and what its actual risks are—then allowing better policy, better medicine and better individual choices to follow.
That philosophy is directly relevant to SENTIA. The question is not simply: How do we remove alcohol? It is: Why do people drink in the first place? What need is alcohol serving? What happens in the brain when it works? And can science give people another option?
Professor Nutt, GABA and social drinking
One of Professor Nutt’s central insights for SENTIA is that alcohol should not be dismissed as some historical mistake.
Humans have repeatedly used it because its chemistry can change the conditions in which social interaction happens.
At low doses, alcohol enhances GABA signalling. Professor Nutt and colleagues identify this GABAergic activity as an important part of the scientific explanation for alcohol’s early relaxing and sociability-promoting effects. GABA is the brain’s principal inhibitory neurotransmitter — part of the regulatory machinery that helps settle neural activity and determine which signals get through.
Alcohol then keeps going. That observation helped frame the GABA Labs research programme: instead of recreating alcohol molecule-for-molecule, investigate whether some of the socially useful biology could be approached more selectively. The first drink gave us the clue. GABA gave us the research question. SENTIA is where that question led.
Professor David Nutt FAQs
- What is Professor David Nutt famous for?
He is known internationally for research into alcohol, drug harms, GABA pharmacology, addiction and psychedelics, as well as for his advocacy of evidence-based drug policy. His 2010 Lancet study ranking alcohol as the most harmful drug overall became one of the best-known studies in the field.
- What does Professor David Nutt do at SENTIA?
Professor Nutt is co-founder and Chief Scientific Officer of GABA Labs, the research company behind SENTIA and co-founder of SENTIA itself. His work on alcohol pharmacology and the GABA system helped establish the scientific rationale for functional alcohol alternatives.
- Why does Professor Nutt study GABA?
GABA is the brain’s principal inhibitory neurotransmitter and an important part of alcohol pharmacology. Understanding how alcohol interacts with GABA helps explain part of the relaxation and sociability associated with lower alcohol exposures.
- Did Professor David Nutt say alcohol is more harmful than heroin?
His 2010 Lancet study found that alcohol produced the highest overall harm score when harms to users and harms to other people were combined. Heroin, crack cocaine and methamphetamine scored higher than alcohol on harm to the individual alone.
- Was Professor David Nutt fired by the UK government?
Yes. In 2009 Home Secretary Alan Johnson removed him as Chair of the Advisory Council on the Misuse of Drugs after disagreements over the relationship between scientific evidence and government drug policy, including the classification of cannabis and MDMA.
- Where can I read more about Professor David Nutt?
His Imperial College profile gives an academic overview of his career, while his Wikipedia entry provides a broader chronology of his research, public-policy work and publications.
Sources
[1] Imperial College London. Professor David Nutt — About and academic profile. Source
[2] Nutt DJ et al. Functional Alternatives to Alcohol. Nutrients. 2022;14:3761. Source
[3] Nutt DJ, King LA, Phillips LD. Drug harms in the UK: a multicriteria decision analysis. The Lancet. 2010;376:1558–1565. Source
[4] Imperial College London. Synthetic alcohol substitute could eliminate health risks and hangovers. 2013. Source
[5] Imperial College London. Study reveals how ecstasy acts on the brain and hints at therapeutic uses. 2014. Source
[6] Sessa B et al. First study of safety and tolerability of MDMA-assisted psychotherapy in patients with alcohol use disorder. BMJ Case Reports. 2019. Source
[7] Drug Science. About Drug Science. Source
[8] Imperial College London / Sense about Science. David Nutt wins the 2013 John Maddox Prize for Standing up for Science. Source
[9] The Standard. The Standard 100: People shaping London in Science & Medicine and Environment. 2024. Source